Keyword: Boston Children's Hospital
A Boston Children's team has developed a method for knocking out the oncogene Lipocalin 2 using CRISPR carried by soft nanoparticles.
Scientists at Boston Children's Hospital have created a gene therapy technique that suppressed heart arrhythmias in mice.
The week’s biotech news included positive results from a study of Merck’s Cavatak in bladder cancer and the use of CRISPR to reverse genetic deafness.
Studies in rats suggest using a novel system to deliver a pufferfish toxin could offer a safe way to block pain.
Scientists at Boston Children's and MIT built CAR-T cells that are inspired by alpaca antibodies and can target protective proteins around solid tumors.
Amazon has announced that its smartspeaker voice assistant Alexa is now HIPAA-compliant and can serve as your very own healthcare valet.
The latest biotech discoveries include a role for CDK inhibition in bone cancer and a gene involved in heart defects.
Scientists at Boston Children’s Hospital are developing a PD-L1-boosting therapy to curb the wayward autoimmune reaction that causes Type 1 diabetes.
Researchers at Boston Children’s Hospital have discovered an approach that could suppress a tumor’s growth by altering its metabolism.
2016 saw GE Healthcare return to growth after a 3.6% decline the year before, making up 15% of GE’s 2016 revenues. After investing $300 million into a new business dedicated to emerging markets, GE experienced great sales growth in those regions.